CINCINNATI, July 1, 2013 (GLOBE NEWSWIRE) -- LSI Industries Inc. (Nasdaq:LYTS) today announced that it has appointed Robert P. Beech to its Board of Directors effective immediately. Mr. Beech has substantial experience as a CEO and senior corporate executive, leading high-technology ventures and strategic initiatives. He is currently engaged as Entrepreneur-in-Residence for biosciences at CincyTechUSA. From 2004 through 2012 he was a senior executive at Intrexon Corporation, a privately held biotechnology company based in Maryland. Prior to 2003, he was CEO of Digineer, Inc., an international healthcare IT software and services company he founded in 1986 and led until 2002. At its peak the company employed over 140 information technology professionals.
Bob received a BS degree in Biology from the University of Miami honors and privileged studies program, graduating magna cum laude. He performed post-graduate studies in microbiology at Florida State University and received a Medical Technology degree in conjunction with Tallahassee Memorial Regional Medical Center. Bob is a long-standing member of the American Society of Clinical Pathology and was involved in clinical diagnostics prior to leading healthcare and biotechnology ventures.
Robert J. Ready, Chief Executive Officer, stated, "We welcome Bob Beech to our board and look forward to his contributions and insights, particularly as they pertain to technology oriented aspects as we pursue solid-state LED lighting and graphics opportunities. From design and engineering, through manufacturing, and sales and service, our business is increasingly being influenced by advanced technologies.""Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995 This document contains certain forward-looking statements that are subject to numerous assumptions, risks or uncertainties. The Private Securities Litigation Reform Act of 1995 provides a safe harbor for forward-looking statements. Forward-looking statements may be identified by words such as "estimates," "anticipates," "projects," "plans," "expects," "intends," "believes," "seeks," "may," "will," "should" or the negative versions of those words and similar expressions, and by the context in which they are used. Such statements, whether expressed or implied, are based upon current expectations of the Company and speak only as of the date made. Actual results could differ materially from those contained in or implied by such forward-looking statements as a result of a variety of risks and uncertainties over which the Company may have no control. These risks and uncertainties include, but are not limited to, the impact of competitive products and services, product demand and market acceptance risks, potential costs associated with litigation and regulatory compliance, reliance on key customers, financial difficulties experienced by customers, the cyclical and seasonal nature of our business, the adequacy of reserves and allowances for doubtful accounts, fluctuations in operating results or costs whether as a result of uncertainties inherent in tax and accounting matters or otherwise, unexpected difficulties in integrating acquired businesses, the ability to retain key employees of acquired businesses, unfavorable economic and market conditions, and the results of asset impairment assessments. You are cautioned to not place undue reliance on these forward-looking statements. In addition to the factors described in this paragraph, the risk factors identified in our Form 10-K and other filings the Company may make with the SEC constitute risks and uncertainties that may affect the financial performance of the Company and are incorporated herein by reference. The Company does not undertake and hereby disclaims any duty to update any forward-looking statements to reflect subsequent events or circumstances.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts